# PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

> **NCT01395030** · PHASE2 · COMPLETED · sponsor: **Queen's Medical Center** · enrollment: 64 (actual)

## Conditions studied

- Adult Hepatocellular Carcinoma
- Localized Resectable Adult Liver Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Computed Tomography
- **DRUG:** 18F-fluoromethylcholine
- **DIAGNOSTIC_TEST:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT01395030
- **Lead sponsor:** Queen's Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-15
- **Primary completion:** 2017-05-31
- **Final completion:** 2018-05-31
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2018-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01395030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01395030, "PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01395030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*